Gemstone Equity Research is bullish on Biocon with a price target of Rs 352 per share.
With CSK’s success in IPL and following valuation, it seems to be time for Indian sports companies to list in the fast maturing stock markets.
CSK could become India’s first sports unicorn after its fourth win of IPL championship, says a report